1 / 5 Stars
1 1 1 1 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
2 / 5 Stars
U.S. News evaluated 48 Target Date 2041-2045 Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
The fund has returned 18.65 percent over the past year, 8.92 percent over the past three years, and 18.14 percent over the past five years.
|Trailing Returns||Updated 02.28.2014|
|Year to date||0.9%|
|3 Years (Annualized)||8.9%|
|5 Years (Annualized)||18.1%|
|10 Years (Annualized)||N/A|
The investment seeks to provide for retirement outcomes based on quantitatively measured risk. The fund normally intends to invest exclusively in affiliated open-end funds and affiliated exchange-traded funds. It is designed for investors expecting to retire or to begin withdrawing assets around the year 2045. The fund holds approximately 84.28% of its assets in underlying funds that invest primarily in equity securities and 15.72% of its assets in underlying funds that invest primarily in fixed income, including underlying funds that invest primarily in money market instruments. It is non-diversified.
Fees are Above Average compared to funds in the same category.
BlackRock LifePath Active 2045 Portfolio has an expense ratio of 0.74 percent.
Risk is Below Average compared to funds in the same category according to Morningstar.